Bivamelagon

Drug identity checked against registry records

Also recorded as LB54640

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Long-Term Study of Bivamelagon in Participants With Hypothalamic Obesity (HO)NCT07156578RYTMPhase 2Enrolling by invitation2028-04-15Estimated
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic ObesityNCT06046443RYTMPhase 2Completed2026-02-09Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.